In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) wh ...

The government will freeze $2 billion in funds because the university refused to comply with its demands. Harvard leaders believed saying no was worth the risk. 7 min read Trump Threatens Harvard ...